[144] F5, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for F5, Inc. (FFIV) shows a proposed sale of 2,701 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $855,055.57. The filing lists three tranches of restricted stock acquired from the issuer on 02/01/2025 (200 shares), 05/01/2025 (2,291 shares), and 08/01/2025 (210 shares), all paid on their acquisition dates. No securities were reported sold in the prior three months. The filer certifies they are not aware of undisclosed material adverse information. The notice documents the intent to sell shares by an individual for whose account the securities were issued and identifies the executing broker and approximate sale date of 09/08/2025.

Positive

• Disclosure complies with Rule 144 requirements, listing broker, share counts, acquisition dates, and aggregate market value
• No sales by the account in the prior three months, reducing concerns about rapid disposition patterns

Negative

• None.

Insights

Securities Analyst

TL;DR Insider plans to sell 2,701 restricted shares worth $855k via Morgan Stanley; transaction appears routine and disclosed under Rule 144.

The filing specifies the sale of restricted common stock granted by the issuer across three grant dates in 2025, aggregated for Rule 144 reporting. The aggregate size relative to typical institutional or company float is not provided, so materiality to FFIV's market capitalization cannot be assessed from this form alone. The lack of sales in the prior three months suggests this is not part of an ongoing rapid disposition pattern. The scheduled trade date is listed as 09/08/2025 and the broker is a major dealer, indicating a standard market-channel disposition.

Corporate Governance Expert

TL;DR Transaction conforms to Rule 144 mechanics; disclosures are routine and include required signer representation about material nonpublic information.

The form documents acquisition as restricted stock from the issuer and includes the required representation regarding absence of undisclosed material adverse information. There is no indication of a trading plan date or Rule 10b5-1 adoption in the remarks, and the filing shows no recent sales to aggregate. From a governance perspective, the form meets Rule 144 disclosure elements but does not provide context on why the sale is occurring or its relation to any executive role or plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2701	855055.57	57447170	09/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2025	Restricted Stock	ISSUER			210	08/01/2025	Not Applicable
Common	05/01/2025	Restricted Stock	ISSUER			2291	05/01/2025	Not Applicable
Common	02/01/2025	Restricted Stock	ISSUER			200	02/01/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for FFIV disclose?

The form discloses a proposed sale of 2,701 common shares valued at $855,055.57, to be sold via Morgan Stanley Smith Barney on NASDAQ around 09/08/2025.

When were the shares being sold acquired?

The shares were acquired as restricted stock from the issuer on 02/01/2025 (200 shares), 05/01/2025 (2,291 shares), and 08/01/2025 (210 shares).

Does the filing report any securities sold in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Who is the executing broker listed on the Form 144?

The executing broker is listed as Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the filing indicate the seller has material nonpublic information?

By signing the notice the person represents they do not know any material adverse information